<DOC>
	<DOCNO>NCT00105443</DOCNO>
	<brief_summary>The purpose study : Find patient receive sorafenib live longer . Find sorafenib effect patient report outcome . Find sorafenib prevents growth shrink liver tumor and/or metastasis . Determine pharmacokinetics ( PK ) patient liver cancer .</brief_summary>
	<brief_title>A Phase III Study Sorafenib Patients With Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description>The following abbreviation use Adverse Event section : - international normalized ratio ( inr ) - Common Terminology Criteria Adverse Events ( ctcae ) - Not Otherwise Specified ( nos ) - Gastrointestinal ( gi ) - Central nervous system ( cns ) - Absolute Neutrophil Count ( anc ) - Alanine aminotransferase ( ALT ) - Aspartate aminotransferase ( AST ) - Creatine phosphokinase ( cpk ) - Gammaglutamyltransferase ( ggt ) - Genitourinary ( gu ) - Atrioventricular ( av )</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Ages eligible study : 18 year , Genders eligible study : Patients life expectancy least 12 week Patients histologically cytologically document Hepatocellular Carcinoma ( HCC ) Patients must least one tumor lesion meet follow criterion : ( 1 ) Accurately measure least one dimension accord RECIST ( Response Evaluation Criteria Solid Tumors ) ( 2 ) Not previously treat local therapy Patients ECOG ( Eastern Cooperative Oncology Group ) PS ( Performance Status ) 0 , 1 , 2 Previous concurrent cancer distinct primary site histology HCC , EXCEPT cervical carcinoma situ , treat basal cell carcinoma , superficial bladder tumor ( Ta [ Noninvasive papillary carcinoma ] , Tis [ Carcinoma situ : `` flat tumor '' ] &amp; T1 [ Tumor invade subepithelial connective tissue ] ) . Any cancer curatively treat &gt; 3 year prior entry permit Renal failure require hemo peritoneal dialysis History cardiac disease Active clinically serious infection Known history human immunodeficiency virus ( HIV ) infection Known central nervous system tumor include metastatic brain disease Patients clinically significant gastrointestinal bleeding within 30 day prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Liver Cancer</keyword>
	<keyword>Cancer</keyword>
</DOC>